MLchartDataset catalogue

Vidaza

Term · Oncology and biomedicine · MLC-T-ONC-009232

A drug that contains the active ingredient azacitidine and is used to treat adults with certain types of myelodysplastic syndromes and children aged 1 month and older with newly diagnosed juvenile myelomonocytic leukemia. It is also being studied in the treatment of other types of cancer. Vidaza stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite.

Table 1. Record
IdentifierMLC-T-ONC-009232
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009232",
  "term": "Vidaza",
  "field": "Oncology and biomedicine",
  "definition": "A drug that contains the active ingredient azacitidine and is used to treat adults with certain types of myelodysplastic syndromes and children aged 1 month and older with newly diagnosed juvenile myelomonocytic leukemia. It is also being studied in the treatment of other types of cancer. Vidaza stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/vidaza/"
}

Record 17,225 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.